1. Home
  2. GBIO vs TLIH Comparison

GBIO vs TLIH Comparison

Compare GBIO & TLIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • TLIH
  • Stock Information
  • Founded
  • GBIO 2016
  • TLIH 1998
  • Country
  • GBIO United States
  • TLIH Singapore
  • Employees
  • GBIO N/A
  • TLIH N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • TLIH
  • Sector
  • GBIO Health Care
  • TLIH
  • Exchange
  • GBIO Nasdaq
  • TLIH Nasdaq
  • Market Cap
  • GBIO 29.5M
  • TLIH 29.1M
  • IPO Year
  • GBIO 2020
  • TLIH 2025
  • Fundamental
  • Price
  • GBIO $5.99
  • TLIH $0.60
  • Analyst Decision
  • GBIO Buy
  • TLIH
  • Analyst Count
  • GBIO 4
  • TLIH 0
  • Target Price
  • GBIO $10.67
  • TLIH N/A
  • AVG Volume (30 Days)
  • GBIO 70.7K
  • TLIH 267.8K
  • Earning Date
  • GBIO 11-05-2025
  • TLIH 01-01-0001
  • Dividend Yield
  • GBIO N/A
  • TLIH N/A
  • EPS Growth
  • GBIO N/A
  • TLIH N/A
  • EPS
  • GBIO N/A
  • TLIH 0.05
  • Revenue
  • GBIO $21,230,000.00
  • TLIH $42,862,063.00
  • Revenue This Year
  • GBIO N/A
  • TLIH N/A
  • Revenue Next Year
  • GBIO N/A
  • TLIH N/A
  • P/E Ratio
  • GBIO N/A
  • TLIH $12.48
  • Revenue Growth
  • GBIO 61.15
  • TLIH N/A
  • 52 Week Low
  • GBIO $3.00
  • TLIH $0.48
  • 52 Week High
  • GBIO $29.10
  • TLIH $7.00
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 54.23
  • TLIH N/A
  • Support Level
  • GBIO $5.51
  • TLIH N/A
  • Resistance Level
  • GBIO $6.04
  • TLIH N/A
  • Average True Range (ATR)
  • GBIO 0.32
  • TLIH 0.00
  • MACD
  • GBIO -0.08
  • TLIH 0.00
  • Stochastic Oscillator
  • GBIO 64.86
  • TLIH 0.00

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About TLIH Ten-League International Holdings Limited Ordinary Shares

Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental and provision of engineering consultancy services to port, construction, civil engineering and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment and port machinery. The company operates in Singapore and Other International Countries.

Share on Social Networks: